Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
288.50B
Market cap288.50B
Price-Earnings ratio
19.36
Price-Earnings ratio19.36
Dividend yield
1.81%
Dividend yield1.81%
Average volume
12.74M
Average volume12.74M
High today
$67.27
High today$67.27
Low today
$64.09
Low today$64.09
Open price
$66.50
Open price$66.50
Volume
10.17M
Volume10.17M
52 Week high
$148.15
52 Week high$148.15
52 Week low
$57.00
52 Week low$57.00

NVO News

TipRanks 15h
Eli Lilly Stock Falls on Reports Novo Nordisk Is Developing New Obesity Treatments

Eli Lilly’s (LLY) stock is down 2% on media reports that rival pharmaceutical company Novo Nordisk (NVO) has struck a deal that will help it develop new obesity...

Benzinga 16h
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs

Septerna Inc. SEPN and Novo Nordisk A/S NVO announced an exclusive global collaboration and license agreement on Wednesday. The pact covers discovering, develo...

Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
Seeking Alpha 18h
Novo Nordisk in pact with Septerna for oral obesity drugs

Septerna (NASDAQ:SEPN) climbed ~63% in the premarket on Wednesday after the Wegovy maker Novo Nordisk (NVO) agreed to jointly develop and commercialize oral sma...

Novo Nordisk in pact with Septerna for oral obesity drugs

Analyst ratings

62%

of 34 ratings
Buy
61.8%
Hold
29.4%
Sell
8.8%

More NVO News

Yahoo Finance 19h
Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases - Yahoo Finance

...

Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases - Yahoo Finance
TipRanks 2d
Hims & Hers Stock Soars as Investors Ask ‘Boom or Bubble’?

Hims & Hers Health (HIMS) is one of the best-performing companies in the U.S. stock market right now, on the back of a catalyst-combo that includes strong Q1 20...

TipRanks 2d
Novo Nordisk price target lowered to DKK 550 from DKK 600 at Morgan Stanley

Morgan Stanley analyst Thibault Boutherin lowered the firm’s price target on Novo Nordisk (NVO) to DKK 550 from DKK 600 and keeps an Equal Weight rating on the...

TipRanks 3d
Pharma Stocks Rally despite Trump’s Plan to Cut Drug Prices

Pharmaceutical stocks initially fell worldwide after President Donald Trump said he plans to sign an executive order to lower U.S. prescription drug prices by m...

Sherwood News 3d
Pharma stocks under pressure as Trump plans executive order to lower drug prices

Pharma stocks under pressure as Trump plans executive order to lower drug prices The Trump administration is definitely on a low prices kick this morning (or a...

Pharma stocks under pressure as Trump plans executive order to lower drug prices
Quartz 3d
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top....

Seeking Alpha 3d
Eli Lilly’s Zepbound shows superior weight loss over Novo Nordisk's Wegovy in trial

Eli Lilly (NYSE:LLY) on Sunday said that its drug Zepbound (tirzepatide) showed superior weight loss over Novo Nordisk's (NVO) Wegovy (semaglutide) in a Phase 3...

Eli Lilly’s Zepbound shows superior weight loss over Novo Nordisk's Wegovy in trial
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.